This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Elite Serum Undergoes Extensive Testing By Bureau Veritas

MIAMI, April 8, 2013 /PRNewswire/ -- Created in 1828, Bureau Veritas is the global leader in Testing, Inspection and Certification (TIC), delivering high quality services to help clients meet the growing challenges of quality, safety, environmental protection and social responsibility.  Elite Serum, made by cosmeceutical laboratory SkinPro, is an award-winning anti-aging eye serum that is widely considered to be the first viable topical alternative to Botulinum Toxin injections. For the past 45 days, Elite Serum has undergone extensive independent testing among a 30 member consumer panel assembled by Bureau Veritas. The results of this testing proves that Elite Serum reduces fine lines and wrinkles, dark under eye circles and under eye puffiness. All of these symptoms were positively affected in varying degrees of efficacy across the panel spectrum.

(Logo: )

Panelists had the following comments to make regarding their experience with Elite Serum:

"I like the feel of the product and I like the syringe dispenser very much."

"This serum did not make the skin around my eyes feel dry like some serums do. I was happy with the product."

"The darkness under my eyes did seem to lessen."

"My right eyelid was closing slightly before using the product. It is now opened fully due to the serum!"

"I only had slight wrinkles and fine lines but I could see a difference after the first couple weeks."

"I have very sensitive skin, but I have found the serum to be very comfortable to use and easy to apply."

"I liked the feel of the product - it never stung my eyes. I also liked that there was no scent to it."

Further to these positive independent panel results that confirm the efficacy of Elite Serum among ordinary consumers, the medical community has also embraced this product with a profound appreciation of its underlying effectiveness. Dr. Mark Weis MD, an anti-aging specialist from the University of Kansas College School of Medicine, remarked, "My patients' experience has confirmed Elite Serum's impressive effectiveness in reducing age-related skin concerns around the eyes." Heralded by both doctors and consumers alike, Elite Serum is available for sale nationwide at select medical centers or online at For more information about this product, please contact SkinPro at 1-800-575-2065.


Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $95.18 1.60%
FB $117.44 -0.95%
GOOG $692.33 -0.84%
TSLA $232.12 -4.00%
YHOO $36.02 -1.40%


Chart of I:DJI
DOW 17,750.91 -140.25 -0.78%
S&P 500 2,063.37 -18.06 -0.87%
NASDAQ 4,763.2240 -54.37 -1.13%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs